🇺🇸 FDA
Patent

US 9249115

N,N1 substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same

granted A61KA61K31/495A61P

Quick answer

US patent 9249115 (N,N1 substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same) held by Vertex Closed Joint Stock Company expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Closed Joint Stock Company
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/495, A61P, A61P9/08, A61P9/10